Raj Patil, Ph.D.

Raj Patil, Ph.D. Email and Phone Number

Chief Scientific Officer at OKYO Pharma leading innovative drug development @ OKYO Pharma
Raj Patil, Ph.D.'s Location
New York, New York, United States, United States
Raj Patil, Ph.D.'s Contact Details

Raj Patil, Ph.D. personal email

n/a

Raj Patil, Ph.D. phone numbers

About Raj Patil, Ph.D.

At OKYO Pharma, my role as Chief Scientific Officer centers on crafting a scientific vision to cultivate an innovative pipeline targeting ocular disorders, while ensuring alignment with our corporate mission. Our team's success in advancing lead drug candidates through non-clinical and clinical stages is a testament to our strategic partnerships in academia and with industry specialists such as CROs and CDMOs.The journey involves providing scientific leadership and interfacing with key opinion leaders to promote OKYO's groundbreaking work. My expertise in drug discovery and life sciences has been honed by strategically managing OKYO's R&D and contributing to the non-clinical and clinical drug development. This has culminated in a robust approach to tackling sight-threatening eye diseases, leveraging our collective expertise in pharmaceuticals to achieve rapid clinical translation and path to drug registration.

Raj Patil, Ph.D.'s Current Company Details
OKYO Pharma

Okyo Pharma

View
Chief Scientific Officer at OKYO Pharma leading innovative drug development
Raj Patil, Ph.D. Work Experience Details
  • Okyo Pharma
    Chief Scientific Officer
    Okyo Pharma Mar 2021 - Present
    Responsible for developing OKYO’s scientific strategy to build a diverse pipeline of novel products targeting ocular disorders and oversee non-clinical and clinical development of lead drug candidates by building partnerships and collaborations with academia and various CROs and CDMOs in order to achieve rapid clinical translation, with a path to registration.Provide visionary and scientific leadership, aligning scientific expectations with the corporate vision and interacting with academic KOLs, investigators and other clinical stakeholders.Represent OKYO and its programs to internal and external audiences, including the Board of Directors, SAB, investment groups, medical and regulatory communities, as well as pharmaceutical/biotechnology industry collaborators/partners.
  • Ora, Inc.
    Vice President Of Research & Development
    Ora, Inc. Mar 2020 - Mar 2021
    Andover, Massachusetts, Us
    Accountable for the global planning, execution, and management of Ora’s R&D Institute.About Ora, Inc.Ora (Ophthalmic Research Associates) is a leading full-service preclinical and clinical ophthalmic drug and device development firm. Over 40 years of global experience has given Ora unparalleled insight into clinical strategy and regulatory requirements, all tailored to meet your study specific needs.
  • Okyo Pharma
    Sr. Director, R&D
    Okyo Pharma Jul 2018 - Mar 2020
    OKYO Pharma (LSE: OKYO) is a biotechnology company developing first-in-class drug candidates for treatment of sight-threatening eye diseases and non-opioid analgesics.
  • Iveena
    Vice President
    Iveena Jun 2013 - Jun 2018
    Salt Lake City, Ut, Us
    Existing therapies rely on drops or injections to deliver medicine, and often do not reach the retina or the inside of cells. iVeena uses novel approaches — including drug delivery from the lens capsule, minimally invasive implants, and intracellular therapy — to reach target tissues for better patient outcomes.
  • Duke-Nus Medical School
    Associate Professor (Sabbatical)
    Duke-Nus Medical School Sep 2015 - Dec 2017
    Singapore, Singapore, Sg
    Dept of Ophthalmology & Visual Sciences Academic Clinical ProgramEngaged in integrating the clinical and discovery expertise to create a unique platform for biomarker/target identification and drug repurposing for retinal diseases in partnership with pharmaceutical industries.
  • Novartis Institutes For Biomedical Research
    Associate Director
    Novartis Institutes For Biomedical Research Jun 2011 - Jun 2013
    Basel, Baselstadt, Ch
    Identified novel preclinical targets for retinal diseases and established project teams to identify lead candidates. Managed and allocated resources needed to achieve group objectives including budgeting and capital expenses and implemented required technologies. Led and collaborated with multidisciplinary project teams of in vitro/in vivo biologists, medicinal chemists and DMPK scientists. Presented periodic briefings/status updates and technical data to senior executives, project leaders, and external collaborators.
  • Alcon Laboratories, Inc.
    Associate Director
    Alcon Laboratories, Inc. Oct 2004 - Jun 2011
    Geneva, Switzerland, Ch
    Managed and executed several academic/industry biomedical research collaborations. Led a team of 6-8 scientists (PhD, MS, BS) focused on advancing the preclinical candidates (small molecules, siRNA and biologics) to clinical development. Established in vitro and in vivo models, and evaluated preclinical candidates. Executed planning, organizing and directing resources (both personnel and technologies) for multiple discovery projects in the therapeutic areas of glaucoma, retina and allergy and inflammation programs. Developed novel technologies and successfully transferred the technology to CROs and academic collaborators for the advancement of Drug Discovery Projects.
  • University Of Nebraska Medical Center
    Associate Professor
    University Of Nebraska Medical Center Sep 2001 - Sep 2004
    Omaha, Nebraska, Us
    Dept of Ophthalmology & Visual SciencesResearch Interest: Glaucoma, AMD and Diabetic Retinopathy
  • Washington University School Of Medicine
    Assistant Professor
    Washington University School Of Medicine Jan 1995 - Aug 2001
    St. Louis, Mo, Us
    Dept of Ophthalmology & Visual SciencesResearch Interest: Glaucoma, Retina, Pharmacology, Physiology

Raj Patil, Ph.D. Skills

Drug Discovery Pharmaceutical Industry Lifesciences Drug Development Target Identification Communication Team Building Team Leadership Cross Functional Team Leadership Strategic Planning Biotechnology Pharmacology Neurodegeneration Assay Development Cro Biochemistry Molecular Biology Technology Transfer Cell Culture Protein Chemistry Pharmaceutical Research Validation Protein Purification Lead Change Therapeutic Areas Cell Biology In Vitro Cell Animal Models High Throughput Screening Elisa Ophthalmology Clinical Development Biomarkers Pharmacokinetics Immunology Drug Delivery Inflammation Biopharmaceuticals Drug Design Physiology Business Development Business Strategy Business Analysis Toxicology Microbiology Clinical Trials Genetics In Vivo Life Sciences

Raj Patil, Ph.D. Education Details

  • University Of Michigan
    University Of Michigan
    Biochemistry And Molecular Biology
  • Savitribai Phule Pune University
    Savitribai Phule Pune University
    Biochemistry

Frequently Asked Questions about Raj Patil, Ph.D.

What company does Raj Patil, Ph.D. work for?

Raj Patil, Ph.D. works for Okyo Pharma

What is Raj Patil, Ph.D.'s role at the current company?

Raj Patil, Ph.D.'s current role is Chief Scientific Officer at OKYO Pharma leading innovative drug development.

What is Raj Patil, Ph.D.'s email address?

Raj Patil, Ph.D.'s email address is ra****@****abs.com

What is Raj Patil, Ph.D.'s direct phone number?

Raj Patil, Ph.D.'s direct phone number is +65 6223*****

What schools did Raj Patil, Ph.D. attend?

Raj Patil, Ph.D. attended University Of Michigan, Savitribai Phule Pune University.

What skills is Raj Patil, Ph.D. known for?

Raj Patil, Ph.D. has skills like Drug Discovery, Pharmaceutical Industry, Lifesciences, Drug Development, Target Identification, Communication, Team Building, Team Leadership, Cross Functional Team Leadership, Strategic Planning, Biotechnology, Pharmacology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.